Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation.

作者信息

Dagorne Anaig, Douet-Guilbert Nathalie, Quintin-Roue Isabelle, Guillerm Gaelle, Couturier Marie-Anne, Berthou Christian, Ianotto Jean-Christophe

出版信息

Ann Hematol. 2013 Mar;92(3):407-9. doi: 10.1007/s00277-012-1560-9. Epub 2012 Sep 2.

DOI:10.1007/s00277-012-1560-9

PMID:22941306

Abstract

摘要

相似文献

Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation.

Ann Hematol. 2013 Mar;92(3):407-9. doi: 10.1007/s00277-012-1560-9. Epub 2012 Sep 2.

Induction of complete remission of acute myeloid leukaemia by pegylated interferon-alpha-2a in a patient with transformed primary myelofibrosis.

Br J Haematol. 2010 Apr;149(1):152-5. doi: 10.1111/j.1365-2141.2009.08029.x. Epub 2009 Dec 8.

[Alpha interferon treatment of chronic myeloproliferative disease associated thrombocytosis].[α干扰素治疗慢性骨髓增殖性疾病相关性血小板增多症]

Duodecim. 1993;109(11):983-9.

A novel prognosis of acute myeloid leukemia: AML-M2 complicate with thrombocythemia after complete remission.

Leuk Res. 2012 Aug;36(8):e166-7. doi: 10.1016/j.leukres.2012.04.011. Epub 2012 May 11.

Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation.异基因造血干细胞移植治疗白血病转化型骨髓纤维化：来自欧洲血液和骨髓移植协会细胞与基因治疗工作组骨髓增殖性肿瘤学组的研究。

Biol Blood Marrow Transplant. 2014 Feb;20(2):279-81. doi: 10.1016/j.bbmt.2013.10.027. Epub 2013 Nov 4.

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study.聚乙二醇干扰素-α2a 治疗骨髓增生性肿瘤相关骨髓纤维化患者的获益和陷阱：法国骨髓增生性肿瘤研究组（FIM）的一项研究。

Haematologica. 2018 Mar;103(3):438-446. doi: 10.3324/haematol.2017.181297. Epub 2017 Dec 7.

Resolution of post-polycythaemic myelofibrosis with a combination of thalidomide and interferon.沙利度胺与干扰素联合使用治疗真性红细胞增多症后骨髓纤维化的疗效

J Clin Pathol. 2012 Aug;65(8):762-3. doi: 10.1136/jclinpath-2011-200598. Epub 2012 Mar 12.

Efficacy and safety of pegylated-interferon α-2a in myelofibrosis: a study by the FIM and GEM French cooperative groups.聚乙二醇干扰素 α-2a 在骨髓纤维化中的疗效和安全性：FIM 和 GEM 法国合作组的研究。

Br J Haematol. 2013 Sep;162(6):783-91. doi: 10.1111/bjh.12459. Epub 2013 Jul 13.

Successful treatment of essential thrombocythemia evolving into agnogenic myeloid metaplasia with interferon-alpha.

J Pediatr Hematol Oncol. 1998 Sep-Oct;20(5):463-6. doi: 10.1097/00043426-199809000-00010.

Reversible bone marrow aplasia induced by pegylated interferon-α-2a therapy in a patient with primary myelofibrosis.聚乙二醇化干扰素-α-2a治疗原发性骨髓纤维化患者引起的可逆性骨髓再生障碍。

J Oncol Pharm Pract. 2014 Oct;20(5):386-92. doi: 10.1177/1078155213504444. Epub 2013 Sep 24.

引用本文的文献

Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients.I 型干扰素信号转导在恶性白血病细胞中有助于 AML 患者的治疗效果。

Cell Death Dis. 2023 Mar 24;14(3):209. doi: 10.1038/s41419-023-05728-w.

Activation of plasmacytoid dendritic cells promotes AML-cell fratricide.浆细胞样树突状细胞的激活促进急性髓系白血病细胞的自相残杀。

Oncotarget. 2021 Apr 27;12(9):878-890. doi: 10.18632/oncotarget.27949.

Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia.干扰素-α和丙戊酸对急性髓系白血病磷酸化蛋白的调节作用。

J Cancer Res Clin Oncol. 2019 Jul;145(7):1729-1749. doi: 10.1007/s00432-019-02931-1. Epub 2019 May 20.

Interferon α may be back on track to treat acute myeloid leukemia.α干扰素治疗急性髓系白血病可能重回正轨。

Oncoimmunology. 2013 Apr 1;2(4):e23619. doi: 10.4161/onci.23619.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验